SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-109725
Filing Date
2008-05-09
Accepted
2008-05-09 15:56:11
Documents
7
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 318380
2 SECOND RESEARCH AND LICENSE AGREEMENT DATED AS OF FEBRUARY 27, 2008 dex101.htm EX-10.1 408826
3 LETTER AGREEMENT DATED FEBRUARY 25, 2008 BETWEEN SIGMA-ALDRICH CORPORATION dex102.htm EX-10.2 25140
4 RULE 13A - 14(A) CERTIFICATION BY PRESIDENT AND CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 8748
5 RULE 13A - 14(A) CERTIFICATION BY PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER dex312.htm EX-31.2 8956
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3260
7 GRAPHIC g18737img001.jpg GRAPHIC 5921
  Complete submission text file 0001193125-08-109725.txt   783054
Mailing Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804
Business Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 08818379
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1